Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Iyo

Showing results (31-40 of 76) with videos related to

Pageof 8
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1996
Brain acetylcholinesterase activity: validation of a PET tracer in a rat model of Alzheimer's diseaseT Irie, K Fukushi, H Namba, et al.
Life Sciences|January 1, 1995
Rolipram, a selective c-AMP phosphodiesterase inhibitor suppresses oro-facial dyskinetic movements in ratsH Sasaki, K Hashimoto, Y Maeda, et al.
Endocrinologia Japonica|June 1, 1989
Inhibition of rat ovarian 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD), 17 alpha-hydroxylase and 17,20 lyase by progestins and danazolS Arakawa, M Mitsuma, M Iyo, et al.
Nuclear Medicine and Biology|June 10, 1998
Glucose and methionine uptake by rat brain tumor treated with prodrug-activated gene therapyH Namba, Y Iwadate, M Iyo, et al.
Research Communications in Chemical Pathology and Pharmacology|January 1, 1994
Relationship between anti-aversive effects of salmon calcitonin and plasma levels of ACTH, beta-endorphin and prostaglandin E2 in miceY Maeda, K Yamada, T Hasegawa, et al.
Psychiatry Research|December 1, 1993
Dopamine D2 and serotonin S2 receptors in susceptibility to methamphetamine psychosis detected by positron emission tomographyM Iyo, M Nishio, T Itoh, et al.
Psychopharmacology|November 10, 2001
The effects of FK506, a specific calcineurin inhibitor, on methamphetamine-induced behavioral change and its sensitization in ratsT Tsukamoto, M Iyo, K Tani, et al.
Lancet (London, England)|June 21, 1997
Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's diseaseM Iyo, H Namba, K Fukushi, et al.
European Journal of Nuclear Medicine|February 5, 1999
Human cerebral acetylcholinesterase activity measured with positron emission tomography: procedure, normal values and effect of ageH Namba, M Iyo, K Fukushi, et al.
Neuropharmacology|March 1, 1991
Quantitative in vivo analysis of benzodiazepine binding sites in the human brain using positron emission tomographyM Iyo, T Itoh, T Yamasaki, et al.
Pageof 8

Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1996
Brain acetylcholinesterase activity: validation of a PET tracer in a rat model of Alzheimer's diseaseT Irie, K Fukushi, H Namba, et al.
Life Sciences|January 1, 1995
Rolipram, a selective c-AMP phosphodiesterase inhibitor suppresses oro-facial dyskinetic movements in ratsH Sasaki, K Hashimoto, Y Maeda, et al.
Endocrinologia Japonica|June 1, 1989
Inhibition of rat ovarian 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD), 17 alpha-hydroxylase and 17,20 lyase by progestins and danazolS Arakawa, M Mitsuma, M Iyo, et al.
Nuclear Medicine and Biology|June 10, 1998
Glucose and methionine uptake by rat brain tumor treated with prodrug-activated gene therapyH Namba, Y Iwadate, M Iyo, et al.
Research Communications in Chemical Pathology and Pharmacology|January 1, 1994
Relationship between anti-aversive effects of salmon calcitonin and plasma levels of ACTH, beta-endorphin and prostaglandin E2 in miceY Maeda, K Yamada, T Hasegawa, et al.
Psychiatry Research|December 1, 1993
Dopamine D2 and serotonin S2 receptors in susceptibility to methamphetamine psychosis detected by positron emission tomographyM Iyo, M Nishio, T Itoh, et al.
Psychopharmacology|November 10, 2001
The effects of FK506, a specific calcineurin inhibitor, on methamphetamine-induced behavioral change and its sensitization in ratsT Tsukamoto, M Iyo, K Tani, et al.
Lancet (London, England)|June 21, 1997
Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's diseaseM Iyo, H Namba, K Fukushi, et al.
European Journal of Nuclear Medicine|February 5, 1999
Human cerebral acetylcholinesterase activity measured with positron emission tomography: procedure, normal values and effect of ageH Namba, M Iyo, K Fukushi, et al.
Neuropharmacology|March 1, 1991
Quantitative in vivo analysis of benzodiazepine binding sites in the human brain using positron emission tomographyM Iyo, T Itoh, T Yamasaki, et al.
Pageof 8